By Iain Gilbert
Date: Wednesday 11 Oct 2023
(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.
By Alexander Bueso
Date: Tuesday 04 Oct 2022
(Sharecast News) - Synairgen announced positive results for its inhaled antiviral protein treatment interferon beta against Covid-19.
By Abigail Townsend
Date: Wednesday 07 Sep 2022
(Sharecast News) - Respiratory drug discovery firm Synairgen has announced positive findings from a clinical trial into its experimental antiviral treatment.
Currency | UK Pounds |
Share Price | 6.50p |
Change Today | -0.29p |
% Change | -4.27 % |
52 Week High | 9.80 |
52 Week Low | 4.88 |
Volume | 555,467 |
Shares Issued | 201.37m |
Market Cap | £13.09m |
RiskGrade | 510 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
14:48 | 15,000 @ 6.33p |
14:41 | 770 @ 6.33p |
14:11 | 4,451 @ 6.74p |
13:55 | 1,283 @ 6.36p |
12:10 | 10,000 @ 6.74p |
You are here: research